A Phase II Study of Venetoclax in Combination With 10-day Decitabine in Relapsed/Refractory Acute Myeloid Leukemia and Relapsed High-risk Myelodysplastic Syndrome
Phase of Trial: Phase II
Latest Information Update: 21 Feb 2018
At a glance
- Drugs Decitabine (Primary) ; Venetoclax (Primary)
- Indications Acute myeloid leukaemia; Myelodysplastic syndromes
- Focus Therapeutic Use
- 15 Feb 2018 Planned End Date changed from 1 Dec 2019 to 1 Dec 2020.
- 23 Jan 2018 New trial record
- 18 Jan 2018 Status changed from not yet recruiting to recruiting.